by
Gus Iversen, Editor in Chief | February 04, 2025
Philips is collaborating with Myocardial Solutions, a North Carolina-based cardiac imaging company, to enhance the use of AI in cardiac magnetic resonance (CMR) imaging.
The collaboration will integrate Myocardial Solutions’ Fast-SENC and MyoStrain technologies with Philips’ imaging systems with the goal of improving early detection of heart disease related to cancer treatments and mitigate the cardiotoxic effects of certain therapies.
These tools can analyze subtle changes in cardiac performance, potentially identifying early signs of heart failure in under 10 minutes. By measuring function across 48 heart segments, the technology may allow clinicians to detect regional dysfunction before it affects overall cardiac health.

Ad Statistics
Times Displayed: 92758
Times Visited: 5940 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Philips' SmartSpeed technology, which incorporates AI-driven Compressed SENSE and Adaptive-CS-Net, is designed to optimize CMR imaging by reducing scan times while maintaining diagnostic accuracy. The company reports that this AI integration can accelerate exams by up to three times while preserving high-resolution imaging capabilities across nearly all clinical protocols. The technology also supports advanced contrast imaging, including T1 mapping, which enhances diagnostic confidence in complex cases.
As part of its sustainability efforts, Philips is also incorporating its BlueSeal MR system into the initiative. The helium-free system is designed to reduce environmental impact while expanding access to advanced imaging, particularly in underserved areas.
“By combining our innovative BlueSeal innovation and SmartSpeed technologies with Myocardial Solutions’ specialized expertise in cardiac care, we aim to redefine the standard of cardiac care, environmental responsibility, and accessibility,” said Ioannis Panagiotelis, business leader of MR at Philips.
The companies are presenting their joint technologies at the Society for Cardiovascular Magnetic Resonance Annual Scientific Congress in Washington, D.C., where Dr. Sebastian Kelle of the German Heart Center and Charité University Medicine in Berlin will discuss his experience using the Philips and Myocardial Solutions technologies.